Ferroptosis in the Pathogenesis of Alzheimer's Disease: The New Evidence for Validation of FAB Model

被引:1
|
作者
Aghajanov, M. I. [1 ]
Harutyunyan, H. S. [1 ,2 ]
Khamperyan, A. Kh. [2 ]
Karapetyan, G. A. [2 ]
Fereshetyan, K. S. [1 ,2 ]
Yenkoyan, K. B. [1 ,2 ,3 ]
机构
[1] Yerevan State Med Univ, Dept Biochem, Yerevan, Armenia
[2] Yerevan State Med Univ, COBRAIN Ctr, Neurosci Lab, Yerevan, Armenia
[3] Yerevan State Med Univ, COBRAIN Ctr, Neurosci Lab, 2 Koryun, Yerevan 0025, Armenia
关键词
ferroptosis; oxidative stress; Alzheimer's disease; experimental models; FAB model; GLUTATHIONE-PEROXIDASE; 4; BETA-AMYLOID PROTEIN; OXIDATIVE STRESS; LIPID-PEROXIDATION; IRON ACCUMULATION; CELL-DEATH; BRAIN; NEURODEGENERATION; NEURONS; DEFERIPRONE;
D O I
10.1134/S1819712423040049
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease is an age-associated progressive disorder, characterized by neurodegeneration and following cognitive decline. Several pathological alterations are implicated in its pathogenesis, hence etiology is still poorly understood. Ferroptosis is an alternative form of cell death, driven by intracellular accumulation of iron with subsequent reactive oxygen species formation, which damages membranes, proteins, and DNA, causing cell death. The imbalance in iron homeostasis is rapidly gaining weight as a neurodegeneration cause, increasing the need to develop in vivo and in vitro models to understand the role of ferroptosis in Alzheimer's disease pathogenesis. This review focuses on the mechanisms of ferroptosis in the pathogenesis of AD, giving a detailed overview of the available in vivo and in vitro methods and their applications, as well as describing in detail the ferrous amyloid buthionine (FAB) model.
引用
收藏
页码:608 / 617
页数:10
相关论文
共 50 条
  • [31] The FAB differentiates Alzheimer's disease and Frontotemporal dementia
    Slachevsky, A
    Villalpondo, JM
    Sarazin, M
    Pillon, B
    Dubois, B
    NEUROLOGY, 2002, 58 (07) : A276 - A276
  • [32] Molecular pathogenesis of Alzheimer's disease
    Iwatsubo, T
    INTERNAL MEDICINE, 2003, 42 (03) : 312 - 312
  • [33] Mitochondria in Alzheimer's Disease Pathogenesis
    Reiss, Allison B.
    Gulkarov, Shelly
    Jacob, Benna
    Srivastava, Ankita
    Pinkhasov, Aaron
    Gomolin, Irving H.
    Stecker, Mark M.
    Wisniewski, Thomas
    De Leon, Joshua
    LIFE-BASEL, 2024, 14 (02):
  • [34] Microglia and Alzheimer's disease pathogenesis
    Streit, WJ
    JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 77 (01) : 1 - 8
  • [35] Complement in the pathogenesis of Alzheimer’s disease
    B. Paul Morgan
    Seminars in Immunopathology, 2018, 40 : 113 - 124
  • [36] Alzheimer's disease: A hypothesis on pathogenesis
    Harman, D
    JOURNAL OF THE AMERICAN AGING ASSOCIATION, 2000, 23 (03) : 147 - 161
  • [37] Pathogenesis of Depression in Alzheimer's Disease
    Zhan, Qingyang
    Kong, Fanyi
    Shao, Shuai
    Zhang, Bo
    Huang, Shuming
    NEUROCHEMICAL RESEARCH, 2024, 49 (03) : 548 - 556
  • [38] Neuroimmunomodulation in the Pathogenesis of Alzheimer's Disease
    Morales, Inelia
    Farias, Gonzalo
    Maccioni, Ricardo B.
    NEUROIMMUNOMODULATION, 2010, 17 (03) : 202 - 204
  • [39] Autophagy in Alzheimer's disease pathogenesis
    Nixon, RA
    Yu, WH
    Cuervo, AM
    Cataldo, AM
    Mathews, PM
    Yang, DS
    Zheng, P
    Peterhoff, CM
    Kumar, A
    Jiang, Y
    Peterson, J
    Schmidt, SD
    Mohan, P
    Duff, K
    Hassinger, L
    Wegiel, J
    Lamb, B
    NEUROBIOLOGY OF AGING, 2004, 25 : S70 - S71
  • [40] ALZHEIMER'S DISEASE: GENETICS TO PATHOGENESIS
    Hardy, John
    INTERNATIONAL SEMINAR ON NUCLEAR WAR AND PLANETARY EMERGENCIES - 38TH SESSION, 2008, : 355 - 363